Aurora Spine Corporation
ASAPFOTCHealthcare● Active
$0.16
+$0.01(+6.04%)
Market Cap$12338567
P/E Ratio—
52W High$0.2563
52W Low$0.157
Aurora Spine Corporation (ASAPF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ASAPF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 27, 2026EPS Actual
-$0.00
Revenue
$0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 27, 2026
After Market Close
ASAPF reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2026 | May 27, 2026 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2025 | Nov 17, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2025 | Aug 28, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2025 | Apr 28, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2024 | Dec 31, 2024 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2024 | Oct 24, 2024 | — | $0.00 | — | $0.00B | — | — |
| — Q3 FY2024 | Aug 21, 2024 | — | -$0.00 | — | $0.00B | $0.00B | +5197.0% |
| — Q2 FY2024 | May 13, 2024 | — | -$0.00 | — | $0.00B | $0.00B | +5089.4% |
Q2 FY2026
May 27, 2026
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2025
Nov 17, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2025
Aug 28, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
Apr 28, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Dec 31, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Oct 24, 2024
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2024
Aug 21, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
May 13, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2013 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2013 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 27, 2026 | — | $0.18 | $0.18 | -2.67% |
| — Q4 FY2025 | Nov 17, 2025 | — | $0.21 | $0.21 | -1.36% |
| — Q3 FY2025 | Aug 28, 2025 | — | $0.21 | $0.21 | +1.52% |
| — Q2 FY2025 | Apr 28, 2025 | — | $0.25 | $0.27 | +5.92% |
| — Q4 FY2024 | Dec 31, 2024 | — | $0.27 | $0.28 | +2.39% |
| — Q4 FY2024 | Oct 24, 2024 | — | $0.28 | $0.28 | +0.00% |
| — Q3 FY2024 | Aug 21, 2024 | — | $0.21 | $0.21 | +0.96% |
| — Q2 FY2024 | May 13, 2024 | — | No price data | $0.20 | — |
Q2 FY2026-2.67%
Report Date
May 27, 2026
EPS Beat/Miss
—
Price Before
$0.18
Price After
$0.18
Q4 FY2025-1.36%
Report Date
Nov 17, 2025
EPS Beat/Miss
—
Price Before
$0.21
Price After
$0.21
Q3 FY2025+1.52%
Report Date
Aug 28, 2025
EPS Beat/Miss
—
Price Before
$0.21
Price After
$0.21
Q2 FY2025+5.92%
Report Date
Apr 28, 2025
EPS Beat/Miss
—
Price Before
$0.25
Price After
$0.27
Q4 FY2024+2.39%
Report Date
Dec 31, 2024
EPS Beat/Miss
—
Price Before
$0.27
Price After
$0.28
Q4 FY2024+0.00%
Report Date
Oct 24, 2024
EPS Beat/Miss
—
Price Before
$0.28
Price After
$0.28
Q3 FY2024+0.96%
Report Date
Aug 21, 2024
EPS Beat/Miss
—
Price Before
$0.21
Price After
$0.21
Q2 FY2024—
Report Date
May 13, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$0.20
Beat Rate0 / 8 quarters
Largest Move+5.92% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ASAPF ends December
Aurora Spine Corporation (ASAPF) most recently reported earnings on May 27, 2026 for Q2 FY2026, posting EPS of $-0.00 (in line with the analyst consensus of —). The next ASAPF earnings date is expected around September 1, 2026.
Each quarter, investors track ASAPF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ASAPF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ASAPF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ASAPF earnings · 4 questionsAurora Spine Corporation's next earnings report is expected around September 1, 2026. ASAPF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ASAPF historically reports after market close (AMC).
ASAPF earnings datewhen is ASAPF earningsASAPF next earnings datewhen does ASAPF report earningsASAPF earnings calendar
▸ Source: FMP · Aurora Spine Corporation SEC filings · US GAAP · Aurora Spine Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026